TETRA-N-BUTYLAMMONIUM DIBROMOAURATE(50481-01-1)
- Name: TETRA-N-BUTYLAMMONIUM DIBROMOAURATE
- Synonyms:TETRA-N-BUTYLAMMONIUM DIBROMOAURATE;Tetrabutylammoniumdibromoaurate
- Molecular Formula:C16H36AuBr2N
- Molecular Weight:599.243
- CAS Registry Number:50481-01-1
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.50481-01-1 TETRA-N-BUTYLAMMONIUM DIBROMOAURATE
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.50481-01-1 TETRA-N-BUTYLAMMONIUM DIBROMOAURATE
Assay:99% Application:Fine chemical intermediates, used as the main raw material for the synthesis of various pesticides, medicines, surfactants, polymer monomers, and antifungal agents
Min. Order:0
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)] CAS No.50481-01-1 TETRA-N-BUTYLAMMONIUM DIBROMOAURATE
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:TETRA-N-BUTYLAMMONIUM DIBROMOAURATE
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.50481-01-1 TETRA-N-BUTYLAMMONIUM DIBROMOAURATE
Assay:>96.0%(T) Appearance:White to Light yellow powder to crystal Storage:Store under inert gas Application:For research use only.
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 54684-83-2/POLYGUANYLIC ACID (5') POTASSIUM SALT
- 524938-53-2/1,2-Dioxane,3,6-dichloro-(9CI)
- 524944-62-5/Cyclopentanecarboxamide, N-(4-amino-1-butyl-1,2,3,6-tetrahydro-2,6-dioxo-5-pyrimidinyl)-
- 59282-46-1/Morpholine, 4-(2-methylene-3-butenyl)- (9CI)
- 524944-74-9/Benzamide, N-(7-butyl-1,3,4,6,7,8-hexahydro-6,8-dioxo-2H-pyrimido[1,6-a]pyrimidin-9-yl)-
- 50463-84-8/Benzoyl chloride, 2-methoxy-6-methyl- (9CI)
- 524944-78-3/Cyclopentanecarboxamide, N-(7-butyl-1,3,4,6,7,8-hexahydro-6,8-dioxo-2H-pyrimido[1,6-a]pyrimidin-9-yl)-
- 59284-60-5/1H-Pyrimido[4,5-f]-1,3,5-triazepine (9CI)
- 50473-50-2/1,3,4-Thiadiazole, 2-(ethylthio)-
- 525537-17-1/Pyrrolidine, 3-ethyl-2-(1-naphthalenyl)- (9CI)
- 526208-41-3/5-Hexen-1-one, 1-(2,3-dihydroxyphenyl)-2-methyl- (9CI)
- 54700-23-1/Oxazolo[3,2-a]benzimidazole, 2-methyl- (9CI)
- 54702-13-5/3-METHYLBUT-3-EN-1-YLBUTYRATE
- 54702-55-5/1,3-Dioxane, 5-ethynyl-2,5-dimethyl-, trans- (9CI)
- 606134-92-3/Piperidine, 1-(butylsulfonyl)-4-(5-phenyl-1H-pyrazol-3-yl)- (9CI)
- 606134-93-4/Piperidine, 1-[(4-methylphenyl)sulfonyl]-4-(5-phenyl-1H-pyrazol-3-yl)- (9CI)
- 606134-96-7/Urea, N-(4-fluorophenyl)-N-(tetrahydro-1,1-dioxido-3-thienyl)- (9CI)
- 606134-97-8/Urea, N-(3-fluorophenyl)-N-[3-(2-furanyl)-1-methylpropyl]- (9CI)
- 50480-99-4/TETRA-N-BUTYLAMMONIUM DICHLOROAURATE
- 50481-01-1/TETRA-N-BUTYLAMMONIUM DIBROMOAURATE
- 50481-03-3/TETRA-N-BUTYLAMMONIUM DIIODOAURATE
- 525537-19-3/Pyrrolidine, 3-ethyl-2-(1-phenylpropyl)- (9CI)
- 526208-27-5/5-Hexen-1-one, 1-(2,5-dihydroxyphenyl)-2-methyl- (9CI)
- 526208-42-4/6-Hepten-1-one, 1-(2,3-dihydroxyphenyl)- (9CI)
- 50531-01-6/2-AMINO-2-CYANO-N-METHYL-ACETAMIDE
- 526208-48-0/6-Hepten-1-one, 1-(2,4-dihydroxyphenyl)- (9CI)
- 535926-66-0/Benzenemethanamine, alpha-cyclopropyl-4-ethoxy-2,5-dimethyl- (9CI)
- 525537-33-1/Pyrrolidine, 3-ethyl-2-(2-phenylethyl)- (9CI)
- 50494-55-8/2-PYRROLIDINONE, [5-14C]
- 525537-46-6/Pyrrolidine, 2-(2-cyclohexylethyl)-3-ethyl- (9CI)